ArticleFrontiers in pediatrics2023

Case report: Emapalumab for active disease control prior to hematopoietic stem cell transplantation in refractory systemic juvenile idiopathic arthritis complicated by macrophage activation syndrome.

Deepak Chellapandian et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.